Mindfulness-Music Intervention in Reducing Anxiety and Stress in Adolescents and Young Adults Receiving Cancer Treatment

Status: Active

Description

This trial studies how well a mindfulness-music intervention works in reducing anxiety and stress in adolescents and young adults receiving cancer treatment. A program designed to incorporate music-based meditation practices and music making activities (e.g., guitar, drums) may help to promote relaxation during cancer treatment.

Eligibility Criteria

Inclusion Criteria

  • Have a diagnosis of any cancer
  • Have begun treatment for cancer and plan to receive active cancer treatment (e.g., radiation, chemotherapy, or oral chemotherapy) over the next eight weeks
  • Signed informed consent/assent
  • Willingness to participate in all study activities
  • Speak/read English

Exclusion Criteria

  • Prognosis < 3 months
  • Self-report inability to physically interact with musical instruments (e.g., hold instruments)
  • Documentation of significant hearing impairment (e.g., deaf)

Locations & Contacts

Massachusetts

Boston
Boston Children's Hospital
Status: Active
Contact: Robert J Knoerl
Phone: 617-632-6386
Email: Robert_knoerl@DFCI.Harvard.edu
Dana-Farber Cancer Institute
Status: Active
Contact: Robert J Knoerl
Phone: 617-632-6386
Email: Robert_knoerl@DFCI.Harvard.edu

Trial Objectives and Outline

PRIMARY OBJECTIVES:

I. Determine the feasibility of adolescents and young adults (AYA) recruitment and adherence to a twelve-week mindfulness-music intervention during cancer treatment.

Ia. Explore AYAs’ perspectives of acceptability and satisfaction with participation in a twelve-week mindfulness-music intervention during cancer treatment.

Ib. Examine potential participants’ reasons for declining participation in a twelve-week mindfulness-music intervention during cancer treatment.

II. Evaluate the impact of a twelve-week mindfulness-music therapy intervention to reduce anxiety and stress in AYAs receiving cancer treatment.

IIa. Explore the impact of a twelve-week mindfulness-music therapy intervention to improve fatigue, depression, social/role functioning, pain intensity, pain interference, and sleep-disturbance.

III. Explore demographic and clinical factors that moderate the impact of a twelve-week mindfulness-music therapy intervention on anxiety and stress severity in AYAs receiving cancer treatment.

IV. Examine the internal consistency reliability and content validity of the Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety 4a and Perceived Stress Scale in adolescents and young adults receiving cancer treatment.

OUTLINE:

Patients attend 4 in-person sessions over 45 minutes each over 12 weeks.

Trial Phase & Type

Trial Phase

No phase specified

Trial Type

Supportive care

Lead Organization

Lead Organization
Dana-Farber Harvard Cancer Center

Principal Investigator
Robert J Knoerl

Trial IDs

Primary ID 18-341
Secondary IDs NCI-2018-03554
Clinicaltrials.gov ID NCT03709225